Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast Cancer
缓解老年乳腺癌患者与癌症相关的认知功能障碍
基本信息
- 批准号:10584472
- 负责人:
- 金额:$ 23.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvant ChemotherapyAffectAgeAreaAttentionAwardBehavior TherapyBehavioralBiologicalBiological FactorsBiometryBreast Cancer therapyCaliforniaCancer EtiologyCaregiversClinicalClinical TrialsCognitionCognitiveCognitive TherapyCognitive agingCohort StudiesCommunity Clinical Oncology ProgramCompensationCoping SkillsDataDevelopmentDigit structureEducational InterventionEducational workshopElderlyEnrollmentEnsureEvaluationFailureFeedbackGeriatric AssessmentGeriatricsGoalsHydrocortisoneImpaired cognitionInstructionIntegration Host FactorsInterventionIntervention StudiesInterviewLeadershipMalignant NeoplasmsManualsMeasurableMeasurementMeasuresMediatingMemoryMentorsMethodsNeuropsychological TestsNeuropsychologyOncologistOncologyParticipantPatient Self-ReportPatientsPerceptionPersonsPopulationPositioning AttributePsychological FactorsPsychologistQuality of lifeRandomizedRandomized, Controlled TrialsReportingResearchResearch PersonnelRiskSalivarySeriesSiteStandardizationStructureSurvivorsTechniquesTestingTimeTrainingTreatment-Related CancerUniversitiesVerbal LearningVideoconferencingWomanWorkactive controlagedarmbehavioral studybiological adaptation to stresscancer riskcancer therapycancer-related cognitive impairmentchemotherapyclinically significantcognitive functioncognitive rehabilitationcognitive reservecomorbiditycomparison controlcoping mechanismdesignexecutive functionexperiencefollow-upfunctional independencehealth information technologyimprovedimproved outcomeinnovationinstrumental activity of daily livinginterestmalignant breast neoplasmmultidisciplinarynegative affectolder patientpreventprimary outcomeprocessing speedprogramsside effectskillsstress managementtelephone basedtoolusabilityverbalyoung cancer survivor
项目摘要
PROJECT SUMMARY
Cancer-related cognitive dysfunction (CRCD) is a significant problem, affecting up to 75% of patients receiving
chemotherapy. Older adults are at greater risk of developing CRCD which can negatively affect their functional
independence and quality of life. Memory and Attention Adaptation Training (MAAT) is a promising tool that
improves perceived cognition in younger cancer survivors with CRCD. For older adults with cancer, MAAT
could be delivered alongside chemotherapy to mitigate the development of CRCD (when risk is highest) and
CRCD-related effects on functional independence for older adults. However, MAAT will require adaptation to
meet the unique needs of older adults to optimize usability and efficacy for this population. I have worked with
my mentors to develop preliminary data for this proposal, demonstrating: 1) older patients and caregivers are
concerned about the cognitive effects of chemotherapy; 2) nearly half of patients with breast cancer receiving
adjuvant chemotherapy report a clinically significant decline in self-reported cognition; 3) it is feasible to study
behavioral interventions in clinical trials for older adults with cancer receiving chemotherapy; and 4) older
adults receiving chemotherapy are interested in participating in a clinical trial evaluating a cognitive
intervention. The overarching goal of this proposal is to adapt MAAT for older adults using input from patient
and caregiver stakeholders, and subsequently gather data on the preliminary effects of the adapted MAAT
(MAAT-Geriatrics [G]) on perceived cognition, objective cognitive measures and functional independence in 85
older adults with breast cancer receiving adjuvant chemotherapy compared to active control condition in a 2-
arm pilot randomized controlled trial (RCT). The research plan combines the use of standardized quantitative
measures of cognition and functional independence with semi-structured interviews (mixed methods), so that
data from both can be integrated to gain a better understanding of MAAT-G's effects that are not fully captured
by traditional quantitative measures alone. Dr. Magnuson is an emerging leader in the field of geriatric
oncology with a focus on cognition. However, in order to become an independent researcher who designs and
implements behavioral interventions to prevent cognitive decline and improve outcomes for older adults with
cancer, she requires additional training and experience in: 1) CRCD measurement and assessment of biologic
mechanisms of CRCD; 2) the design, execution and analysis of RCTs involving cognitive interventions; 3) the
design and analysis of mixed methods trials; and 4) development and refinement of her leadership skills. An
outstanding mentor team supports this proposal (Mohile/Hurria–geriatric oncology/leadership,
Janelsins/Ferguson–CRCD/cognitive interventions, Lin–cognitive aging, Morrow–behavioral interventions,
Wittink–mixed methods, Culakova-biostatistics). The training and research plan will position Dr. Magnuson to
become one of the few geriatric oncologists studying cognition and cognitive interventions, and develop a
much-needed cognitive intervention for older adults at risk for developing CRCD.
项目摘要
癌症相关的认知功能障碍(CRCD)是一个重要的问题,影响高达75%的接受化疗的患者。
化疗老年人患CRCD的风险更大,这可能对他们的功能产生负面影响。
独立性和生活质量。记忆和注意力适应训练(MAAT)是一种很有前途的工具,
改善患有CRCD的年轻癌症幸存者的感知认知。对于患有癌症的老年人,MAAT
可以与化疗一起提供,以减轻CRCD的发展(当风险最高时),
CRCD对老年人功能独立性的相关影响然而,MAAT将需要进行调整,
满足老年人的独特需求,以优化该人群的可用性和功效。I have worked with
我的导师为这项提议开发了初步数据,证明:1)老年患者和护理人员
关注化疗的认知影响; 2)近一半的乳腺癌患者接受
辅助化疗报告自我报告的认知有临床意义的下降; 3)研究
接受化疗的老年癌症患者临床试验中的行为干预;以及4)老年人
接受化疗的成年人有兴趣参加一项临床试验,
干预该提案的总体目标是利用患者的输入,为老年人调整MAAT
和照顾者利益相关者,并随后收集关于经调整的MAAT的初步影响的数据
(MAAT-Geriatrics [G])对85名老年人的感知认知、客观认知测量和功能独立性的研究
接受辅助化疗的老年乳腺癌患者与积极对照组相比,
随机对照试验(RCT)。该研究计划结合使用标准化的定量
采用半结构化访谈(混合方法)测量认知和功能独立性,以便
从这两个方面获得的数据可以综合起来,以便更好地了解MAAT-G的影响,而这些影响还没有被完全捕捉到
传统的量化方法。Magnuson博士是老年医学领域的新兴领导者
关注认知的肿瘤学然而,为了成为一名独立的研究人员,
实施行为干预,以预防认知能力下降,并改善老年人的结果,
她需要额外的培训和经验:1)CRCD测量和生物学评估
CRCD的机制; 2)涉及认知干预的RCT的设计,执行和分析; 3)
混合方法试验的设计和分析;以及4)发展和完善她的领导技能。一个
杰出的导师团队支持这一提议(Mohile/Hurria-老年肿瘤学/领导,
Janelsins/Ferguson-CRCD/认知干预,Lin-认知老化,Morrow-行为干预,
Wittink-混合方法,Culakova-生物统计学)。培训和研究计划将使马格努森博士
成为为数不多的研究认知和认知干预的老年肿瘤学家之一,并开发出一种
对有患CRCD风险的老年人进行急需的认知干预。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.
拥抱复杂性:患有癌症相关认知能力下降的老年人——国际老年肿瘤学青年协会立场文件。
- DOI:10.1016/j.jgo.2019.09.002
- 发表时间:2020
- 期刊:
- 影响因子:3
- 作者:Pergolotti,Mackenzi;Battisti,NicolòMatteoLuca;Padgett,Lynne;Sleight,AlixG;Abdallah,Maya;Newman,Robin;VanDyk,Kathleen;Covington,KelleyR;Williams,GrantR;vandenBos,Frederiek;Pollock,YaoYao;Salerno,ElizabethA;Magnuson,Allison
- 通讯作者:Magnuson,Allison
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.
- DOI:10.1158/1078-0432.ccr-20-3868
- 发表时间:2021-05-01
- 期刊:
- 影响因子:0
- 作者:Magnuson A;Bruinooge SS;Singh H;Wilner KD;Jalal S;Lichtman SM;Kluetz PG;Lyman GH;Klepin HD;Fleury ME;Hirsch B;Melemed A;Arnaldez FI;Basu Roy U;Schenkel C;Sherwood S;Garrett-Mayer E
- 通讯作者:Garrett-Mayer E
Identifying Geriatric Oncology Competencies for Medical Oncology Trainees: A Modified Delphi Consensus Study.
确定肿瘤内科实习生的老年肿瘤学能力:修改后的德尔菲共识研究。
- DOI:10.1634/theoncologist.2019-0950
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Hsu,Tina;Kessler,ElizabethR;Parker,IraR;Dale,William;Gajra,Ajeet;Holmes,HollyM;Maggiore,RonaldJ;Magnuson,Allison;McKoy,JuneM;Hurria,Arti
- 通讯作者:Hurria,Arti
Cognitive assessment for older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative.
患有癌症的老年人的认知评估:年轻的国际老年肿瘤学和护理学会
- DOI:10.1016/j.jgo.2021.10.004
- 发表时间:2022
- 期刊:
- 影响因子:3
- 作者:Romanovsky,Lindy;Magnuson,Allison;Puts,Martine
- 通讯作者:Puts,Martine
Medical Decision-Making in Oncology for Patients Lacking Capacity.
- DOI:10.1200/edbk_280279
- 发表时间:2020-03
- 期刊:
- 影响因子:0
- 作者:Marron JM;Kyi K;Appelbaum PS;Magnuson A
- 通讯作者:Magnuson A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allison Marian Magnuson其他文献
Allison Marian Magnuson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allison Marian Magnuson', 18)}}的其他基金
Enhancing Triadic Communication About Cognition for Older Adults with Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
加强患有阿尔茨海默病或相关痴呆症的老年人面临癌症管理决策时关于认知的三元沟通
- 批准号:
10617370 - 财政年份:2022
- 资助金额:
$ 23.86万 - 项目类别:
Enhancing Triadic Communication About Cognition for Older Adults with Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
加强患有阿尔茨海默病或相关痴呆症的老年人面临癌症管理决策时关于认知的三元沟通
- 批准号:
10436554 - 财政年份:2022
- 资助金额:
$ 23.86万 - 项目类别:
Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast Cancer
缓解老年乳腺癌患者与癌症相关的认知功能障碍
- 批准号:
9811864 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Feasibility of the Memory and Attention Adaptation Training-Geriatrics Intervention in Older Cancer Survivors with Mild Cognitive Impairment
轻度认知障碍老年癌症幸存者记忆和注意力适应训练老年病干预的可行性
- 批准号:
10288545 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast Cancer
缓解老年乳腺癌患者与癌症相关的认知功能障碍
- 批准号:
9973127 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast Cancer
缓解老年乳腺癌患者与癌症相关的认知功能障碍
- 批准号:
10356909 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
相似海外基金
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
用于辅助化疗筛选的显微结直肠癌肝转移 3D 工程模型
- 批准号:
10556192 - 财政年份:2023
- 资助金额:
$ 23.86万 - 项目类别:
Developing Digital Pathology Biomarkers for Response to Neoadjuvant and Adjuvant Chemotherapy in Breast Cancer
开发数字病理学生物标志物以应对乳腺癌新辅助和辅助化疗
- 批准号:
10315227 - 财政年份:2021
- 资助金额:
$ 23.86万 - 项目类别:
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III)
循环肿瘤 DNA 分析为 III 期结直肠癌辅助化疗提供信息:多中心 II/III 期随机对照试验 (DYNAMIC-III)
- 批准号:
443988 - 财政年份:2021
- 资助金额:
$ 23.86万 - 项目类别:
Operating Grants
Establishment of new selection system for adjuvant chemotherapy of colorectal cancer
结直肠癌辅助化疗新选择体系的建立
- 批准号:
20K09011 - 财政年份:2020
- 资助金额:
$ 23.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improved survival by Helicobacter pylori-modulated immunity in gastric cancer patients with adjuvant chemotherapy
幽门螺杆菌调节免疫力可改善接受辅助化疗的胃癌患者的生存率
- 批准号:
19K09130 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new strategy of adjuvant chemotherapy for lung cancer based on the expression of anti-aging gene Klotho
基于抗衰老基因Klotho表达的肺癌辅助化疗新策略
- 批准号:
19K18225 - 财政年份:2019
- 资助金额:
$ 23.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer
预测胰腺癌S-1辅助化疗效果的新候选因素
- 批准号:
18K16337 - 财政年份:2018
- 资助金额:
$ 23.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy
项目2-骨髓源性抑制细胞的代谢调节以提高新辅助化疗和免疫疗法的疗效
- 批准号:
10005254 - 财政年份:2018
- 资助金额:
$ 23.86万 - 项目类别:
Radiogenomic tools for prediction of breast cancer neo-adjuvant chemotherapy response from pre-treatment MRI
通过治疗前 MRI 预测乳腺癌新辅助化疗反应的放射基因组学工具
- 批准号:
9763320 - 财政年份:2018
- 资助金额:
$ 23.86万 - 项目类别:
Analysis of the molecular mechanism for the prognostic biomarker of adjuvant chemotherapy
辅助化疗预后生物标志物的分子机制分析
- 批准号:
18K07341 - 财政年份:2018
- 资助金额:
$ 23.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)